An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.
Y. Ung
No relevant relationships to disclose
C. Gu
No relevant relationships to disclose
K. Cline
No relevant relationships to disclose
A. Sun
No relevant relationships to disclose
R. M. MacRae
No relevant relationships to disclose
J. R. Wright
No relevant relationships to disclose
E. Yu
No relevant relationships to disclose
L. Ehrlich
No relevant relationships to disclose
K. Y. Gulenchyn
No relevant relationships to disclose
H. Shulman
No relevant relationships to disclose
I. S. Dayes
No relevant relationships to disclose
S. K. Dhesy-Thind
No relevant relationships to disclose
G. E. Darling
No relevant relationships to disclose
N. B. Leighl
No relevant relationships to disclose
W. K. Evans
No relevant relationships to disclose
J. A. Julian
No relevant relationships to disclose
M. N. Levine
No relevant relationships to disclose